Sentry Investment Management LLC Vertex Pharmaceuticals Inc Transaction History

Sentry Investment Management LLC

$225 Million
Q2 2024

A detailed history of Sentry Investment Management LLC transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Sentry Investment Management LLC holds 1,240 shares of VRTX stock, worth $587,958. This represents 0.26% of its overall portfolio holdings.

Number of Shares

1,240

Previous 1,494 17.0%

Holding current value

$587,958

Previous $625,000 7.04%

% of portfolio

0.26%

Previous 0.24%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 07, 2024	SELL	$392.81 - $485.53 $99,773 - $123,324	-254 Reduced 17.0%	1,240 $581,000
Q4 2023 Jan 30, 2024	SELL	$343.0 - $410.68 $686 - $821	-2 Reduced 0.13%	1,494 $608,000
Q3 2023 Nov 03, 2023	SELL	$338.18 - $362.46 $108,555 - $116,349	-321 Reduced 17.67%	1,496 $520,000
Q2 2023 Jul 27, 2023	BUY	$314.42 - $351.91 $38,673 - $43,284	123 Added 7.26%	1,817 $639,000
Q1 2023 Apr 26, 2023	SELL	$283.23 - $323.1 $26,906 - $30,694	-95 Reduced 5.31%	1,694 $534,000
Q4 2022 Feb 08, 2023	BUY	$285.76 - $321.48 $16,002 - $18,002	56 Added 3.23%	1,789 $517,000
Q2 2022 Aug 02, 2022	SELL	$234.96 - $292.55 $17,622 - $21,941	-75 Reduced 4.15%	1,733 $488,000
Q1 2022 May 09, 2022	SELL	$221.42 - $260.97 $167,614 - $197,554	-757 Reduced 29.51%	1,808 $472,000
Q4 2021 Feb 11, 2022	BUY	$177.01 - $223.45 $28,144 - $35,528	159 Added 6.61%	2,565 $563,000
Q3 2021 Nov 03, 2021	SELL	$181.39 - $202.99 $63,849 - $71,452	-352 Reduced 12.76%	2,406 $436,000
Q1 2021 Apr 21, 2021	SELL	$207.02 - $241.31 $5.92 Million - $6.9 Million	-28,589 Reduced 91.2%	2,758 $593,000
Q3 2020 Nov 05, 2020	BUY	$255.65 - $303.1 $457,102 - $541,942	1,788 Added 6.05%	31,347 $8.53 Million
Q2 2020 Aug 07, 2020	BUY	$225.48 - $295.8 $3.02 Million - $3.96 Million	13,398 Added 82.9%	29,559 $8.58 Million
Q1 2020 May 05, 2020	BUY	$199.77 - $247.81 $129,450 - $160,580	648 Added 4.18%	16,161 $3.85 Million
Q2 2019 Aug 12, 2019	BUY	$164.61 - $190.37 $100,247 - $115,935	609 Added 4.09%	15,513 $2.85 Million
Q1 2019 May 08, 2019	SELL	$163.73 - $194.7 $216,614 - $257,588	-1,323 Reduced 8.15%	14,904 $2.74 Million
Q4 2018 Feb 11, 2019	SELL	$151.91 - $192.21 $64,561 - $81,689	-425 Reduced 2.55%	16,227 $2.69 Million
Q2 2018 Aug 10, 2018	SELL	$145.72 - $169.96 $184,627 - $215,339	-1,267 Reduced 7.07%	16,652 $2.83 Million
Q1 2018 May 02, 2018	SELL	$151.6 - $177.13 $260,448 - $304,309	-1,718 Reduced 8.75%	17,919 $2.92 Million
Q3 2017 Nov 13, 2017	BUY	$148.13 - $162.24 $153,166 - $167,756	1,034 Added 5.56%	19,637 $2.99 Million
Q2 2017 Aug 21, 2017	BUY	N/A	18,603	18,603 $2.4 Million

Others Institutions Holding VRTX

# of Institutions

1,707

Shares Held

226M

Call Options Held

1.2M

Put Options Held

1.59M

View Full List

About VERTEX PHARMACEUTICALS INC

Ticker VRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 256,691,008
Market Cap $122B
Description
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...

More about VRTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Sentry Investment Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sentry Investment Management LLC with notifications on news.

Account

Sentry Investment Management LLC Vertex Pharmaceuticals Inc Transaction History